Free Trial

Bolsonaro Justifies Sinovac Criticism

BRAZIL

President Bolsonaro has decided to use the recent Sinovac efficacy study as a personal win by proclaiming he was right to question the Chinese Covid-19 vaccine.


He has repeatedly criticised the Sinovac shot, claiming it to be untrustworthy. He chose today to tell supporters, "now they are seeing the truth."


Passing the blame of greenlighting wholly over to ANVISA it does not change the fact the government closed a deal with the Butantan Institute to buy up to 100 million doses of the Chinese vaccine. The government will receive an initial 46 million doses with another 54-million dose option later.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.